Phoenix Nest Competitors and Similar CompaniesClear all
Phoenix Nest's competitors and similar companies include Human Stem Cells Institute, Chinook Therapeutics, Dr Lal PathLabs and Mesoblast.
 Phoenix Nest Phoenix Nest is a biotech company that provides treatment for the disease Sanfilippo syndrome. |  Human Stem Cells Institute Human Stem Cells Institute is a biomedical technologies and healthcare solutions provider. |  Chinook Therapeutics Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases. |  Dr Lal PathLabs Dr Lal PathLabs is an international service provider of diagnostic and related healthcare tests. |  Mesoblast Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine. | |
Founding Date | Founding Date 2012 | Founding Date 2003 | Founding Date 2011 | Founding Date 1949 | Founding Date 2004 |
Type | Type Private | Type Public | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations New York, US HQ | Locations Moscow, RU HQ | Locations Seattle, US HQ | Locations Gurugram, IN HQ | Locations Melbourne, AU HQ Singapore, SG New York, US |
Employees | Employees 10 | Employees N/A | Employees 27 | Employees 4,099 | Employees 73 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ₽1.7b (FY, 2025) | Revenue (est.) $6.1m (FY, 2022) | Revenue (est.) ₹24.6b (FY, 2025) | Revenue (est.) $17.2m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ₽330.8m (FY, 2025) | Cost of goods N/A | Cost of goods ₹4.8b (FY, 2025) | Cost of goods $1.2m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ₽1.4b (FY, 2025) | Gross profit N/A | Gross profit ₹19.8b (FY, 2025) | Gross profit $16.1m (FY, 2025) |
Net income | Net income N/A | Net income ₽107.7m (FY, 2025) | Net income ($187.9m) (FY, 2022) | Net income ₹4.9b (FY, 2025) | Net income ($102.1m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 171m | Total funding raised N/A | Total funding raised $ 56.2m |
For sources of this data, please see the company profile
View Company Profiles
Human Stem Cells Institute
HQ
Moscow, RU
Human Stem Cells Institute is a biomedical technologies and healthcare solutions provider.
View companyChinook Therapeutics
HQ
Seattle, US
Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases.
View companyDr Lal PathLabs
HQ
Gurugram, IN
Employees
4,099
Dr Lal PathLabs is an international service provider of diagnostic and related healthcare tests.
View companyMesoblast
HQ
Melbourne, AU
Employees
73
Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine.
View company